11,200 Shares in Encompass Health Co. (NYSE:EHC) Purchased by Paradigm Asset Management Co. LLC

Paradigm Asset Management Co. LLC purchased a new position in shares of Encompass Health Co. (NYSE:EHC) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 11,200 shares of the company’s stock, valued at approximately $1,034,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of EHC. Point72 Asset Management L.P. grew its holdings in Encompass Health by 2,458.5% during the third quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock worth $83,990,000 after purchasing an additional 835,135 shares during the period. Jennison Associates LLC bought a new position in Encompass Health during the fourth quarter worth about $52,094,000. abrdn plc bought a new position in Encompass Health during the fourth quarter worth about $17,846,000. Thrivent Financial for Lutherans lifted its position in Encompass Health by 26.0% during the third quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company’s stock worth $73,494,000 after acquiring an additional 156,938 shares during the last quarter. Finally, Franklin Resources Inc. lifted its position in Encompass Health by 22.0% during the third quarter. Franklin Resources Inc. now owns 700,021 shares of the company’s stock worth $67,412,000 after acquiring an additional 126,000 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Down 1.7 %

NYSE EHC opened at $99.87 on Friday. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a 1-year low of $73.68 and a 1-year high of $104.55. The company has a 50 day moving average of $96.00 and a 200-day moving average of $95.76. The company has a market cap of $10.06 billion, a price-to-earnings ratio of 22.39, a PEG ratio of 2.35 and a beta of 0.90.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, equities research analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 17th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.68%. Encompass Health’s dividend payout ratio is currently 15.25%.

Analyst Ratings Changes

Several brokerages have issued reports on EHC. Truist Financial restated a “buy” rating and set a $116.00 price objective (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. KeyCorp raised their price objective on shares of Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Monday, February 10th. Royal Bank of Canada restated an “outperform” rating and set a $110.00 price objective on shares of Encompass Health in a research report on Tuesday, February 11th. StockNews.com upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, February 15th. Finally, William Blair restated an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Ten equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, Encompass Health presently has an average rating of “Buy” and a consensus price target of $107.67.

Insider Buying and Selling at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the business’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 2.10% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.